Folate Stress Induces Apoptosis via p53-dependent de Novo Ceramide Synthesis and Up-regulation of Ceramide Synthase 6*
暂无分享,去创建一个
B. Ogretmen | S. Krupenko | Besim Ogretmen | N. Krupenko | Sergey A Krupenko | L Alexis Hoeferlin | Baharan Fekry | Natalia I Krupenko | L. A. Hoeferlin | B. Fekry
[1] R. Paules,et al. Folate deficiency in normal human fibroblasts leads to altered expression of genes primarily linked to cell signaling, the cytoskeleton and extracellular matrix. , 2007, The Journal of nutritional biochemistry.
[2] S. Krupenko,et al. Ectopic expression of 10-formyltetrahydrofolate dehydrogenase in A549 cells induces G1 cell cycle arrest and apoptosis. , 2003, Molecular cancer research : MCR.
[3] Y. Hannun,et al. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. , 1991, The Journal of biological chemistry.
[4] Jian Yu,et al. PUMA, a potent killer with or without p53 , 2008, Oncogene.
[5] Y. Hannun,et al. Increases in neutral, Mg2+-dependent and acidic, Mg2+-independent sphingomyelinase activities precede commitment to apoptosis and are not a consequence of caspase 3-like activity in Molt-4 cells in response to thymidylate synthase inhibition by GW1843. , 1998, Blood.
[6] P. Codogno,et al. Regulation of autophagy by sphingolipids. , 2011, Anti-cancer agents in medicinal chemistry.
[7] A. Bielawska,et al. De novo N-palmitoylsphingosine synthesis is the major biochemical mechanism of ceramide accumulation following p53 up-regulation. , 2008, Prostaglandins & other lipid mediators.
[8] J. Shinoda,et al. Molecular mechanisms of TNF-α-induced ceramide formation in human glioma cells:P53-mediated oxidant stress-dependent and -independent pathways , 2004, Cell Death and Differentiation.
[9] K. Hirschi,et al. Nutrient regulation of cell cycle progression. , 2004, Annual review of nutrition.
[10] D. Green,et al. PUMA cooperates with direct activator proteins to promote mitochondrial outer membrane permeabilization and apoptosis , 2009, Cell cycle.
[11] I. Pogribny,et al. Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. , 1997, The American journal of clinical nutrition.
[12] Y. Hannun,et al. Serine Palmitoyltransferase Regulates de NovoCeramide Generation during Etoposide-induced Apoptosis* , 2000, The Journal of Biological Chemistry.
[13] B. Ames,et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[14] Y. Hannun,et al. De Novo Ceramide Regulates the Alternative Splicing of Caspase 9 and Bcl-x in A549 Lung Adenocarcinoma Cells , 2002, The Journal of Biological Chemistry.
[15] A. Merrill,et al. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. , 1991, The Journal of biological chemistry.
[16] A. Horváth,et al. Ceramide synthesis enhances transport of GPI‐anchored proteins to the Golgi apparatus in yeast. , 1994, The EMBO journal.
[17] A. Bielawska,et al. Role for Ceramide in Cell Cycle Arrest (*) , 1995, The Journal of Biological Chemistry.
[18] A. Bielawska,et al. Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. , 2006, Methods.
[19] D. Priest,et al. Cancer cells activate p53 in response to 10-formyltetrahydrofolate dehydrogenase expression. , 2005, The Biochemical journal.
[20] S. Krupenko,et al. Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway , 2007, Oncogene.
[21] S. Nakashima,et al. Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells , 2000, Cell Death and Differentiation.
[22] Y. Hannun,et al. Tumor necrosis factor-alpha (TNF-alpha) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF-alpha from activation of nuclear factor-kappa B. , 1993, The Journal of biological chemistry.
[23] Y. Hannun,et al. Glutathione Regulation of Neutral Sphingomyelinase in Tumor Necrosis Factor-α-induced Cell Death* , 1998, The Journal of Biological Chemistry.
[24] Jian Yu,et al. No PUMA, no death: implications for p53-dependent apoptosis. , 2003, Cancer cell.
[25] Y. Hannun,et al. Many Ceramides* , 2011, The Journal of Biological Chemistry.
[26] P. Codogno,et al. Regulation of Autophagy by Sphingosine Kinase 1 and Its Role in Cell Survival during Nutrient Starvation* , 2006, Journal of Biological Chemistry.
[27] Y. Asmann,et al. Gene Expression Profiling of NF-1-Associated and Sporadic Pilocytic Astrocytoma Identifies Aldehyde Dehydrogenase 1 Family Member L1 (ALDH1L1) as an Underexpressed Candidate Biomarker in Aggressive Subtypes , 2008, Journal of neuropathology and experimental neurology.
[28] R. Moran,et al. The antifolates: evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of folate analogs. , 2010, Current opinion in investigational drugs.
[29] Mammalian ceramide synthases , 2010, IUBMB life.
[30] A. Haimovitz-Friedman,et al. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis , 1994, The Journal of experimental medicine.
[31] C. López-Larrea,et al. Autophagy and self-defense. , 2012, Advances in experimental medicine and biology.
[32] C. Bauvy,et al. Ceramide-mediated Macroautophagy Involves Inhibition of Protein Kinase B and Up-regulation of Beclin 1* , 2004, Journal of Biological Chemistry.
[33] S. Krupenko,et al. Activation of p21-Dependent G1/G2 Arrest in the Absence of DNA Damage as an Antiapoptotic Response to Metabolic Stress. , 2011, Genes & cancer.
[34] A. Kihara,et al. Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. , 2005, The Biochemical journal.
[35] L. Obeid,et al. Developmentally Regulated Ceramide Synthase 6 Increases Mitochondrial Ca2+ Loading Capacity and Promotes Apoptosis* , 2010, The Journal of Biological Chemistry.
[36] Y. Hannun,et al. Ceramide synthases at the centre of sphingolipid metabolism and biology. , 2012, The Biochemical journal.
[37] S. Krupenko,et al. Epigenetic Silencing of ALDH1L1, a Metabolic Regulator of Cellular Proliferation, in Cancers. , 2011, Genes & cancer.
[38] Y. Hannun,et al. Ceramide in apoptosis: an overview and current perspectives. , 2002, Biochimica et biophysica acta.
[39] Y. Hannun,et al. Antiapoptotic roles of ceramide‐synthase‐6‐generated C16‐ceramide via selective regulation of the ATF6/ CHOP arm of ER‐stress‐response pathways , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[40] P. Lu,et al. Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase 3 in colon cancer cells , 2008, Oncogene.
[41] S. Krupenko,et al. 10-Formyltetrahydrofolate Dehydrogenase–Induced c-Jun-NH2-Kinase Pathways Diverge at the c-Jun-NH2-Kinase Substrate Level in Cells with Different p53 Status , 2009, Molecular Cancer Research.
[42] Hui-Yun Wang,et al. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma , 2012, Medical Oncology.
[43] L. Obeid,et al. The BCL-2 Protein BAK Is Required for Long-chain Ceramide Generation during Apoptosis* , 2010, The Journal of Biological Chemistry.
[44] T. Kuwana,et al. Sphingolipid Metabolism Cooperates with BAK and BAX to Promote the Mitochondrial Pathway of Apoptosis , 2012, Cell.
[45] J. Selhub,et al. Regulation of Folate-mediated One-carbon Metabolism by 10-Formyltetrahydrofolate Dehydrogenase* , 2006, Journal of Biological Chemistry.
[46] G. Dbaibo,et al. p53-dependent ceramide response to genotoxic stress. , 1998, The Journal of clinical investigation.
[47] Yusuf A. Hannun,et al. Biologically active sphingolipids in cancer pathogenesis and treatment , 2004, Nature Reviews Cancer.
[48] S. Krupenko. FDH: an aldehyde dehydrogenase fusion enzyme in folate metabolism. , 2009, Chemico-biological interactions.
[49] L. Gu,et al. Folate deficiency, mismatch repair-dependent apoptosis, and human disease. , 2003, The Journal of nutritional biochemistry.
[50] L. Bailey,et al. Folate metabolism and requirements. , 1999, The Journal of nutrition.
[51] Y. Hannun,et al. The complex life of simple sphingolipids , 2004, EMBO reports.
[52] J. Pietenpol,et al. High Affinity Insertion/Deletion Lesion Binding by p53 , 1999, The Journal of Biological Chemistry.
[53] A. Merrill,et al. Modulation of Ceramide Synthase Activity via Dimerization* , 2012, The Journal of Biological Chemistry.
[54] P. Stover,et al. Folate-mediated one-carbon metabolism. , 2008, Vitamins and hormones.
[55] R. Testi,et al. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase , 1994, The Journal of experimental medicine.
[56] J. Trepel,et al. Impact of extracellular folate levels on global gene expression. , 2001, Molecular pharmacology.
[57] R. Schwartz,et al. Differentially expressed genes in embryonic cardiac tissues of mice lacking Folr1 gene activity , 2007, BMC Developmental Biology.
[58] J. Bertino,et al. Cancer research: from folate antagonism to molecular targets. , 2009, Best practice & research. Clinical haematology.
[59] S. Krupenko,et al. 10-formyltetrahydrofolate dehydrogenase, one of the major folate enzymes, is down-regulated in tumor tissues and possesses suppressor effects on cancer cells. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[60] S. Ponnusamy,et al. Concerted functions of HDAC1 and microRNA-574-5p repress alternatively spliced ceramide synthase 1 expression in human cancer cells , 2012, EMBO molecular medicine.
[61] K. Scotto,et al. Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals , 1995, Cell.
[62] S. Krupenko,et al. ALDH1L1 Inhibits Cell Motility Via Dephosphorylation of Cofilin by PP1 and PP2A , 2010, Oncogene.